Correlation Between Estrella Immunopharma and Theriva Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and Theriva Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and Theriva Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Estrella Immunopharma and Theriva Biologics, you can compare the effects of market volatilities on Estrella Immunopharma and Theriva Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of Theriva Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and Theriva Biologics.

Diversification Opportunities for Estrella Immunopharma and Theriva Biologics

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Estrella and Theriva is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and Theriva Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theriva Biologics and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with Theriva Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theriva Biologics has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and Theriva Biologics go up and down completely randomly.

Pair Corralation between Estrella Immunopharma and Theriva Biologics

Assuming the 90 days horizon Estrella Immunopharma is expected to generate 4.9 times more return on investment than Theriva Biologics. However, Estrella Immunopharma is 4.9 times more volatile than Theriva Biologics. It trades about 0.16 of its potential returns per unit of risk. Theriva Biologics is currently generating about -0.03 per unit of risk. If you would invest  2.86  in Estrella Immunopharma on August 30, 2024 and sell it today you would earn a total of  6.24  from holding Estrella Immunopharma or generate 218.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy44.24%
ValuesDaily Returns

Estrella Immunopharma  vs.  Theriva Biologics

 Performance 
       Timeline  
Estrella Immunopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Estrella Immunopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly fragile basic indicators, Estrella Immunopharma showed solid returns over the last few months and may actually be approaching a breakup point.
Theriva Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Theriva Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Estrella Immunopharma and Theriva Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Estrella Immunopharma and Theriva Biologics

The main advantage of trading using opposite Estrella Immunopharma and Theriva Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, Theriva Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theriva Biologics will offset losses from the drop in Theriva Biologics' long position.
The idea behind Estrella Immunopharma and Theriva Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges